Prevalence and severity of thrombocytopenia in patients with hyperferritinemia

References

• Schaffner M, Rosenstein L, Ballas Z, et al. Significance of hyperferritinemia in hospitalized adults. Am J Med Sci. 2017;354(2):152–158.
   PubMed Web of Science ®Google Scholar
• Belfeki N, Strazzulla A, Picque M, et al. Extreme hyperferritinemia: etiological spectrum and impact on prognosis. Reumatismo. 2020;71(4):199–202.
   PubMed Web of Science ®Google Scholar
• Rosário C, Zandman-Goddard G, Meyron-Holtz EG, et al. The hyperferritinemic syndrome: macrophage activation syndrome, still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185.
   PubMed Web of Science ®Google Scholar
• Lodha A, Pillai A, Reddy P, et al. Using first-contact serum ferritin to predict severe thrombocytopenia in dengue patients: determination and validation in independent cohorts. Infect Dis. 2022;54(6):425–430.
   PubMed Web of Science ®Google Scholar
• Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205–1208.
   PubMed Web of Science ®Google Scholar
• Gómez-Pastora J, Weigand M, Kim J, et al. Hyperferritinemia in critically ill COVID-19 patients - is ferritin the product of inflammation or a pathogenic mediator? ClinChimActa. 2020;509:249–251.
   PubMed Web of Science ®Google Scholar
• Cheong JW, Kim HJ, Lee KH, et al. Korean society of hematology acute myeloid leukemia/myelodysplastic syndrome working party. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia. Transfusion. 2014;54(6):1542–1551.
   PubMed Web of Science ®Google Scholar
• Huscenot T, Luc D, Ballon OW, et al. Iron deficiency anemia, a rare and potentially underestimated cause of thrombocytopenia and a differential diagnosis of immune thrombocytopenia (ITP): results from a retrospective case-controlled study. Blood. 2018;132(Suppl 1):4984.
   Google Scholar
• Giordano L, Llanos-Chea A, Monde A, et al. Recurrent severe iron deficiency anemia and thrombocytopenia in an adolescent male. J Pediatr Hematol Oncol. 2019;41(2):e116–e118.
   PubMed Web of Science ®Google Scholar
• Breccia M, Voso MT, Aloe Spiriti MA, et al. An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms. Ann Hematol. 2015;94(5):771–777.
   PubMed Web of Science ®Google Scholar
• Getawa S, Aynalem M, Bayleyegn B, et al. The global prevalence of thrombocytopenia among HIV-infected adults: A systematic review and meta-analysis. Int J Infect Dis. 2021;105:495–504.
   PubMed Web of Science ®Google Scholar
• Sackett K, Cunderlik M, Sahni N, et al. Extreme hyperferritinemia: causes and impact on diagnostic reasoning. Am J Clin Pathol. 2016;145(5):646–650.
   PubMed Web of Science ®Google Scholar
• Miao WJ, Qi JQ, Song BQ, et al. Clinical significance of pretransplant serum ferritin level in patients with prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Zhongguo Shi Yan Xue Ye XueZaZhi. 2021;29(3):869–875.
   PubMedGoogle Scholar
• Babikir M, Ahmad R, Soliman A, et al. Iron-Induced thrombocytopenia: a mini-review of the literature and suggested mechanisms. Cureus. 2020;12(9):e10201.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Espinoza JL, Fujiwara R, et al. Excessive reactive iron impairs hematopoiesis by affecting both immature hematopoietic cells and stromal cells. Cells. 2019;8(3):226.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Zhao Y, Guo J, et al. Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells frommyelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway. Cell Death Dis. 2018;9(5):515.
   PubMedGoogle Scholar
• Sousa L, Oliveira MM, Pessôa MTC, et al. Iron overload: effects on cellular biochemistry. Clin Chim Acta. 2020;504:180–189.
   PubMed Web of Science ®Google Scholar
• Chang Y, Chen X, Tian Y, et al. Downregulation of microRNA-155-5p prevents immune thrombocytopenia by promoting macrophage M2 polarization via the SOCS1-dependent PD1/ PDL1 pathway. Life Sci. 2020;257:118057.
   PubMed Web of Science ®Google Scholar
• Weigelin B, Bakker G-J, Friedl P. Third harmonic generation microscopy of cells and tissue organization. J. Cell Sci. 2016;129:245–255.
   PubMed Web of Science ®Google Scholar
• Zhao HY, Zhang YY, Xing T, et al. M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity. Sig Transduct Target Ther. 2021;6:234.
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723–737.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xu P, Guo L, et al. Tumor necrosis factor-α blockade corrects monocyte/macrophage imbalance in primary immune thrombocytopenia. Thromb Haemost. 2021;121(6):767–781.
   PubMedGoogle Scholar
• Zhou Y, Que KT, Zhang Z, et al. Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway. Cancer Med. 2018;7(8):4012–4022.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Zhao Y, Guo J, et al. Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway. Cell Death Dis. 2018;9(5):515.
   PubMedGoogle Scholar
• Bauduer F, Recanzone H. Transfusional iron overload in heavily transfused patients: real-life data from a 10-year retrospective study of 611 cases managed in a French general hospital. Transfus Clin Biol. 2022;29(3):236–242.
   PubMed Web of Science ®Google Scholar
• Breccia M, Voso MT, Aloe Spiriti MA, et al. An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms. Ann Hematol. 2015;94(5):771–777.
   PubMed Web of Science ®Google Scholar